Latest Breaking News On - Duke cancer institute - Page 10 : comparemela.com

Prostate Cancer Whole Gland Ablation Offers Similar Oncologic Outcomes

Systematic review focused on cryoablation and high-intensity focused ultrasound. Whole-gland ablation for prostate cancer offers good oncologic outcomes for select patients, according to real-world data.

United statesNorth carolinaThomasj polascikDuke university medical centre in durhamDuke cancer instituteDuke university medical centre

Forty Cancer Centers Vow to Use Patient Navigation Codes

Seven insurers also announced new commitments to begin paying for navigation services

White houseDistrict of columbiaUnited statesNorth carolinaUniversity of minnesotaJoann sweasyStates jill bidenStewart greenebaum comprehensive cancer centerNorris comprehensive cancer centerDuke cancer instituteMercy healthBaptist health cancer careAbramson cancer centerSidney kimmel cancer centerMoores cancer centerMercy health system oncology practices

CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib

Strickler, Leung, Dasari, and O'Neill discuss adverse effect monitoring and management with standard agents for patients with colorectal cancer.

United statesNorth carolinaJohnh stricklerAshling wahnerMichael leungMargot oneillArvindn dasariUniversity of texas md anderson cancer centerDuke cancer instituteDivision of cancer medicineDuke cancer institute in durhamLive on airTaiho pharmaceuticalOnclive insideMedical oncologyCancer center

Duke Health

Duke HealthNews, press releases, and expert sources for journalists in science, medicine & business

National institutes of healthDuke healthDuke cancer instituteArtificial intelligenceNational institutesNew england journalDuke cancerCancer instituteCience newsCience headlinesResearch newsCience news releasesCience press releasesEdical newsHealth newsMbargoed science news

SESAUA 2024: Association of PSA Response and Overall Survival in Patients with mHSPC: Results from the Phase 3 ARASENS Trial

SESAUA 2024: Association of PSA Response and Overall Survival in Patients with mHSPC: Results from the Phase 3 ARASENS Trial
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesDanielj georgeDaniel georgeZachary klaassenSoutheastern section of the american urological associationGeorgia cancer centerDuke cancer instituteUrologic oncologistAssociate professorAmerican urological associationAnnual meetingMonth prostate specific antigenAndrogen deprivationProstate specific antigen kineticsOverall survivalRadiological progression free survival